BCV
ADCT icon

Banque Cantonale Vaudoise’s ADC Therapeutics ADCT Stock Holding History

Banque Cantonale Vaudoise’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,000
Closed -$8K – 1226
2022
Q2 		$8K Hold
1,000
– – ﹤0.01% 1199
2022
Q1 		$15K Hold
1,000
– – ﹤0.01% 1178
2021
Q4 		$20K Hold
1,000
– – ﹤0.01% 1184
2021
Q3 		$27K Sell
1,000
-4,100
-80% -$105K ﹤0.01% 1127
2021
Q2 		$124K Buy
5,100
+4,100
+410% +$95.1K 0.01% 925
2021
Q1 		$24K Buy
+1,000
New +$29K ﹤0.01% 1063

Other funds holding ADCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCG
Vantage Consulting Group Virginia Beach, Virginia $19.7M AUM 280.87% 1-Year Est. Return
GGH
GCM Grosvenor Holdings Chicago, Illinois $901M AUM 28.6% 1-Year Est. Return

Banque Cantonale Vaudoise's ADCT Position: Q3 2022 in Review

Banque Cantonale Vaudoise sold out of ADC Therapeutics (ADCT) in Q3 2022, closing a stake of 1,000 shares — an estimated $8K sold.

Banque Cantonale Vaudoise first reported a position in ADCT in Q1 2021 and held it in 6 quarters. The position peaked at $124K in Q2 2021. 66 funds tracked by Wall St. Rank hold ADCT as of Q3 2022.

  • Banque Cantonale Vaudoise reported no remaining ADC Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 1,000 ADC Therapeutics shares in Q3 2022, an estimated $8K.
  • Banque Cantonale Vaudoise first reported a position in ADC Therapeutics in Q1 2021 and held it in 6 quarters.
  • Banque Cantonale Vaudoise's ADC Therapeutics position peaked at $124K in Q2 2021.
  • 66 funds tracked by Wall St. Rank held ADC Therapeutics as of Q3 2022.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2022, filed 17 Oct 2022.